enVVeno Medical Q3 EPS $(0.35) Misses $(0.33) Estimate
Portfolio Pulse from Benzinga Newsdesk
enVVeno Medical reported a Q3 EPS of $(0.35), missing the consensus estimate of $(0.33) by 6.06%. Despite the miss, this represents a 22.22% improvement from the $(0.45) loss per share in the same period last year.
October 31, 2024 | 1:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
enVVeno Medical's Q3 EPS of $(0.35) missed the consensus estimate of $(0.33), but showed a 22.22% improvement from last year's $(0.45) loss per share.
The EPS miss is likely to have a negative short-term impact on NVNO's stock price as it did not meet analyst expectations. However, the improvement from last year's EPS may mitigate some negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100